Abstract
Epstein-Barr virus (EBV) was used to immortalize human peripheral B lymphocytes committed to the productio of autoantibodies in healthy subjects and in patients with various autoimmune diseases. EBV-transformed B lymphocytes producing human monoclonal autoantibodies were fused with the human-mouse heterohybridoma F3B6 cells to stabilize the production of monoclonal antibodies (mAb). The present method of generating human B cell clones producing mAbs now makes it possible to analyze in detail the nature of human autoantibodies with respect to antigen-binding specificity, affinity, corresponding autoepitopes, and the variable (V) region structure.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 159-168 |
| Number of pages | 10 |
| Journal | ImmunoMethods |
| Volume | 1 |
| Issue number | 3 |
| DOIs | |
| State | Published - Dec 1992 |
| Externally published | Yes |
ASJC Scopus subject areas
- Immunology